Indonesia presents significant opportunities for international pharmaceutical companies, but entering the market requires more than identifying demand.

Companies evaluating an Indonesia market entry need to understand how the local pharmaceutical ecosystem operates, determine an appropriate business and distribution model, identify credible local partners, and navigate relevant regulatory requirements. These considerations were at the center of a series of business discussions facilitated by SAN Consulting (PT Strategi Andalan Nusantara) on 5–6 August 2026, bringing together Japanese and Indonesian stakeholders to explore potential opportunities in Indonesia’s pharmaceutical sector.

SAN Consulting explores potential collaboration with The Nanto Bank to support Japanese companies, particularly from Nara Prefecture, in understanding and entering the Indonesian market.

A short overview of why foreign companies need a structured approach before entering the Indonesian market.

A brief article on why partner sourcing and due diligence matter in cross-border market expansion.